| Market Cap | 63Cr 55Cr 51Cr 47Cr 88Cr 6.06TCr 89Cr 602.27Cr 235.48Cr 3.03TCr 237.78Cr 232.62Cr 10TCr | P/E 2027 * |
-9.26x | P/E 2028 * | -21.6x |
|---|---|---|---|---|---|
| Enterprise Value | 61Cr 52Cr 49Cr 45Cr 84Cr 5.8TCr 86Cr 576.79Cr 225.52Cr 2.9TCr 227.72Cr 222.78Cr 9.65TCr | EV / Sales 2027 * |
0.54x | EV / Sales 2028 * | 0.5x |
| Free-Float |
98.49% | Yield 2027 * |
-
| Yield 2028 * | - |
Last Transcript: Tilray, Inc.
| 1 day | -5.59% |
| Manager | Title | Age | Since |
|---|---|---|---|
Irwin Simon
CEO | Chief Executive Officer | 67 | 01/05/2021 |
Carl Merton
DFI | Director of Finance/CFO | 57 | 01/05/2021 |
Roger Savell
ADM | Chief Administrative Officer | 64 | 31/03/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Irwin Simon
CHM | Chairman | 67 | 01/05/2021 |
David Clanachan
BRD | Director/Board Member | 64 | 30/04/2021 |
John Herhalt
BRD | Director/Board Member | 69 | 01/05/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -5.59% | -15.99% | - | - | 63Cr | ||
| -2.25% | -0.47% | +68.30% | +116.05% | 1,05200Cr | ||
| -0.66% | +0.43% | +47.39% | +51.02% | 63TCr | ||
| -0.54% | +1.39% | +20.69% | +64.61% | 44TCr | ||
| -0.15% | -4.90% | +38.59% | +37.55% | 35TCr | ||
| +0.38% | -2.95% | +22.79% | +36.95% | 29TCr | ||
| +1.19% | -3.22% | -1.14% | +7.52% | 24TCr | ||
| -0.63% | +1.04% | +40.05% | +56.67% | 22TCr | ||
| -0.64% | -4.13% | -15.54% | -53.95% | 20TCr | ||
| +0.16% | +3.87% | +16.89% | +77.38% | 17TCr | ||
| Average | -0.87% | -0.77% | +26.45% | +43.76% | 39.95TCr | |
| Weighted average by Cap. | -0.81% | -0.63% | +38.72% | +62.08% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 112.28Cr 97Cr 91Cr 83Cr 155.81Cr 11TCr 158.38Cr 1.07TCr 417.48Cr 5.38TCr 421.55Cr 412.4Cr 18TCr | 117.67Cr 101.63Cr 96Cr 87Cr 163.3Cr 11TCr 165.99Cr 1.12TCr 437.53Cr 5.63TCr 441.81Cr 432.22Cr 19TCr |
| Net income | -6.15Cr -5.31Cr -4.99Cr -4.54Cr -8.53Cr -587.98Cr -8.67Cr -58Cr -23Cr -294.44Cr -23Cr -23Cr -978.46Cr | -2.69Cr -2.32Cr -2.18Cr -1.98Cr -3.73Cr -256.88Cr -3.79Cr -26Cr -9.99Cr -128.64Cr -10Cr -9.87Cr -427.48Cr |
| Net Debt | -2.68Cr -2.31Cr -2.17Cr -1.98Cr -3.72Cr -256.23Cr -3.78Cr -25Cr -9.96Cr -128.31Cr -10Cr -9.84Cr -426.4Cr | -3.93Cr -3.39Cr -3.19Cr -2.9Cr -5.45Cr -375.85Cr -5.54Cr -37Cr -15Cr -188.22Cr -15Cr -14Cr -625.46Cr |
Employees
3,595
Sector
Pharmaceuticals

















